… No studies have compared the efficacy of anifrolumab and … insights into the comparative
efficacy of different treatments [37… anifrolumab trials – to compare the efficacy of anifrolumab and …

… anifrolumab has potential as a targeted treatment for patients with SLE. Anifrolumab demonstrated
efficacy … (14), British Isles Lupus Assessment Group (BILAG)–based Composite Lupus …

… the safety and efficacy of anifrolumab in patients with SLE … In our department, we have
analysed the safety and efficacy of … evaluated the safety and efficacy of anifrolumab in patients on …

… has been approved for the treatment of systemic lupus erythematosus (SLE). Clinical trials
have shown that anifrolumab is effective in cutaneous lupus erythematosus (CLE) associated …

… Systemic lupus erythematosus (SLE) is a chronic autoimmune … We aimed to evaluate the
efficacy of anifrolumab on organ … about the efficacy of anifrolumab for lupus nephritis cannot be …

… , anifrolumab 300 mg was more efficacious than 150 mg in TULIP-1 [8]. In MUSE, anifrolumab
300 mg was numerically more efficacious … rates seen with anifrolumab 1000 mg [10, 14]. …

… Here, we review the clinical efficacy and safety of anifrolumab and discuss the potential …
treated with anifrolumab. In summary, greater efficacy was seen with anifrolumab compared with …

Objectives Evaluate the efficacy and safety of anifrolumab in the subpopulation of Japanese
patients with systemic lupus erythematosus (SLE) in phase 3 TULIP-2 trial. Methods TULIP-…

… signature was observed in patients receiving anifrolumab who had a high interferon … efficacy
has not been investigated. Clinical efficacy was observed in patients receiving anifrolumab …

… Therefore, this study aimed to increase the accuracy of the efficacy and safety estimates of
anifrolumab in active SLE by implementing a meta-analysis approach to different endpoints of …